Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins

por Dwojak, M, Bobrowicz, M, Bil, J, Bojarczuk, K, Pyrzynska, B, Siernicka, M, Malenda, A, Lech-Maranda, E, Tomczak, W, Giannopoulos, K, Golab, J, Winiarska, M
Publicado 2015

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy

por Firczuk, M, Gabrysiak, M, Barankiewicz, J, Domagala, A, Nowis, D, Kujawa, M, Jankowska-Steifer, E, Wachowska, M, Glodkowska-Mrowka, E, Korsak, B, Winiarska, M, Golab, J
Publicado 2013